Interestingly, in mice exposed to hypoxia or SUGEN-induced pulmonary hypertension, targeting both CCR2 and CCR5 prevented or reversed PH more efficiently than targeting either receptor alone [24]. The gene discussed is CCR5; the disease is pulmonary arterial hypertension.